TORONTO, ONTARIO--(Marketwired - April 24, 2013) - First Generation Capital Inc. ("FGCI"), announced today that it acquired 18,750,000 common shares of Trimel Pharmaceuticals Corporation (the "Issuer"). The purchase was made pursuant to the Issuer's final prospectus, dated April 18, 2013, at $0.80 per common share. FGCI is a private investment holding company owned by Mr. Ian Ihnatowycz (collectively with FGCI, the "Offerors").
Following the purchase, the Offerors hold a total of 21,752,500 common shares of the Issuer, corresponding to a securityholding percentage, calculated in accordance with National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues of approximately 15.45%.
The securities of the Issuer were acquired for investment purposes. Depending upon the circumstances, the Offerors may, from time to time, acquire additional securities or related financial instruments of the Issuer or dispose of all or a portion of the securities or related financial instruments of the Issuer previously acquired.
The issuance of this news release is not an admission that any entity named herein owns or controls any described securities or is a joint actor with another named entity.
Additional information is provided in the early warning report filed on www.sedar.com.
Contact Information:
the early warning report please contact:
First Generation Capital Inc.
40 King Street West, Suite 3515, Toronto, ON M5H 3Y2
Attention: Ian Ihnatowycz, President and CEO
(416) 304-9910